Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy.

Literature DB >> 3813674

Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy.

J K French, N P Hurst, M L O'Donnell, W H Betts.

Abstract

The accumulation of chloroquine and hydroxychloroquine in unfractionated mononuclear cells and in purified monocytes, lymphocytes, and neutrophil polymorphonuclear leucocytes (PMN) was measured in vitro. Accumulation of both drugs in leucocytes was time and dose dependent. Cellular levels comparable to those found during antirheumatic therapy were achieved by preincubation for 60 minutes with up to 0.1 mM chloroquine or hydroxychloroquine.

Entities: Chemical Species

Mesh：

Substances：

Year: 1987 PMID： 3813674 PMCID： PMC1002056 DOI： 10.1136/ard.46.1.42

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

13 in total

1. Size distribution, electronic recognition, and counting of human blood monocytes.

Authors: H Loos; B Blok-Schut; B Kipp; R van Doorn; L Meerhof
Journal: Blood Date: 1976-11 Impact factor: 22.113

2. Antioxidant action of antimalarials.

Authors: Y Miyachi; A Yoshioka; S Imamura; Y Niwa
Journal: Ann Rheum Dis Date: 1986-03 Impact factor: 19.103

3. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors: A Böyum
Journal: Scand J Clin Lab Invest Suppl Date: 1968

4. Discontinuous density gradient separation of human mononuclear leucocytes using Percoll as gradient medium.

Authors: A J Ulmer; H D Flad
Journal: J Immunol Methods Date: 1979 Impact factor: 2.303

5. Chloroquine and ammonium ion inhibit receptor-mediated endocytosis of mannose-glycoconjugates by macrophages: apparent inhibition of receptor recycling.

Authors: C Tietze; P Schlesinger; P Stahl
Journal: Biochem Biophys Res Commun Date: 1980-03-13 Impact factor: 3.575

6. Chloroquine: its effect on leucocyte auto- and heterophagocytosis.

Authors: C J Jones; M I Jayson
Journal: Ann Rheum Dis Date: 1984-04 Impact factor: 19.103

7. Pharmacologic actions of 4-aminoquinoline compounds.

Authors: A H Mackenzie
Journal: Am J Med Date: 1983-07-18 Impact factor: 4.965

8. Chloroquine inhibits the production of a mononuclear cell factor by inhibition of lectin binding.

Authors: D G Baker; D F Baumgarten; J P Dwyer
Journal: Arthritis Rheum Date: 1984-08

9. Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate.

Authors: E W McChesney
Journal: Am J Med Date: 1983-07-18 Impact factor: 4.965

10. Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling.

Authors: A Gonzalez-Noriega; J H Grubb; V Talkad; W S Sly
Journal: J Cell Biol Date: 1980-06 Impact factor: 10.539

19 in total

1. Immunomodulatory drugs regulate HMGB1 release from activated human monocytes.

Authors: Hanna Schierbeck; Heidi Wähämaa; Ulf Andersson; Helena Erlandsson Harris
Journal: Mol Med Date: 2010-04-09 Impact factor: 6.354

2. The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum.

Authors: S Kaewpongsri; K Sriprawat; R Suwanarusk; D E Kyle; U Lek-Uthai; M Leimanis; K M Lwin; A P Phyo; J Zwang; B Russell; F Nosten; L Renia
Journal: Antimicrob Agents Chemother Date: 2010-12-28 Impact factor: 5.191

3. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?

Authors: J S Dixon; M Greenwood; H A Bird
Journal: Clin Rheumatol Date: 1988-06 Impact factor: 2.980

4. Studies on the mechanism of inhibition of chemotactic tripeptide stimulated human neutrophil polymorphonuclear leucocyte superoxide production by chloroquine and hydroxychloroquine.

Authors: N P Hurst; J K French; L Gorjatschko; W H Betts
Journal: Ann Rheum Dis Date: 1987-10 Impact factor: 19.103

5. Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes.

Authors: W-U Kim; S-A Yoo; S-Y Min; S-H Park; H-S Koh; S-W Song; C-S Cho
Journal: Clin Exp Immunol Date: 2006-06 Impact factor: 4.330

6. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation.

Authors: S M Levitz; T S Harrison; A Tabuni; X Liu
Journal: J Clin Invest Date: 1997-09-15 Impact factor: 14.808

Review 7. Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors: J Ducharme; R Farinotti
Journal: Clin Pharmacokinet Date: 1996-10 Impact factor: 6.447

8. Identification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by statins and antimalarial agents.

Authors: Nhat-Tu Le; Yuichiro Takei; Yuki Izawa-Ishizawa; Kyung-Sun Heo; Hakjoo Lee; Alan V Smrcka; Benjamin L Miller; Kyung Ae Ko; Sara Ture; Craig Morrell; Keigi Fujiwara; Masashi Akaike; Jun-ichi Abe
Journal: J Immunol Date: 2014-09-03 Impact factor: 5.422

9. Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.

Authors: Jeffrey A Martinson; Carlos J Montoya; Xiomara Usuga; Rollie Ronquillo; Alan L Landay; Seema N Desai
Journal: Antimicrob Agents Chemother Date: 2009-11-30 Impact factor: 5.191

10. Chloroquine differentially modulates inflammatory cytokine expression in RAW 264.7 cells in response to inactivated Staphylococcus aureus.

Authors: Dan Zhou; Yi Liu; Li-Hui Xu; Dong-Yun Ouyang; Hao Pan; Xiao-Yu Zhang; Gao-Xiang Zhao; Xian-Hui He
Journal: Inflammation Date: 2015-04 Impact factor: 4.092